4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-19-053491
CEO sold 2,983 shares at $39.65 ($118,276)
- CEO acquired 5,937 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2019-10-15 | Option exercise | +5,937 | 5,937 | D | ||
| DAVIS STEPHEN CEO | 2019-10-15 | Sale | −2,983 | $39.65 | $118,276 | 2,954 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2019-10-15 | Option exercise · Restricted Stock Units | −5,937 | 17,813 | D | ||
| Open-market sales · 2,983 sh · avg $39.65 · $118,276 | |||||||
Loading xslF345X03/doc4.xml…